GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GeneFerm Biotechnology Co Ltd (ROCO:1796) » Definitions » Additional Paid-In Capital

GeneFerm Biotechnology Co (ROCO:1796) Additional Paid-In Capital : NT$294.3 Mil(As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is GeneFerm Biotechnology Co Additional Paid-In Capital?


GeneFerm Biotechnology Co's quarterly additional paid-in capital stayed the same from Dec. 2023 (NT$294.3 Mil) to Mar. 2024 (NT$294.3 Mil) and stayed the same from Mar. 2024 (NT$294.3 Mil) to Jun. 2024 (NT$294.3 Mil).

GeneFerm Biotechnology Co's annual additional paid-in capital increased from Dec. 2021 (NT$270.7 Mil) to Dec. 2022 (NT$294.3 Mil) but then stayed the same from Dec. 2022 (NT$294.3 Mil) to Dec. 2023 (NT$294.3 Mil).


GeneFerm Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for GeneFerm Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneFerm Biotechnology Co Additional Paid-In Capital Chart

GeneFerm Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 121.45 102.01 270.69 294.34 294.34

GeneFerm Biotechnology Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 294.34 294.34 294.34 294.34 294.34

GeneFerm Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

GeneFerm Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of GeneFerm Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneFerm Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 33, Xingong Road, Xinying District, Tainan, TWN, 74144
GeneFerm Biotechnology Co Ltd is a fermentation company based in Taiwan. It is engaged in manufacturing health food and supplements which include Fermented Microbial products, Fermented Fungi products, Probiotics and Extraction, and Concentration products among others.

GeneFerm Biotechnology Co Headlines

No Headlines